Indication

Chronic phase chronic myeloid leukemia

Chronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells. Read more about Chronic phase chronic myeloid leukemia

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Chronic phase chronic myeloid leukemia therapies.

Showing 1–4 of 4 drugs

ICLUSIG (ponatinib HCl)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·BLASTIC PHASE CHRONIC MYELOID LEUKEMIA·+3
MILLENNIUM PHAR
Filter & compare in the drug finder →Opens the drug finder with Chronic phase chronic myeloid leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic phase chronic myeloid leukemia.

Chronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells.

It predominantly affects adults and is pathophysiologically driven by the Philadelphia chromosome—a reciprocal balanced translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2)—which generates the constitutively active BCR::ABL1 tyrosine kinase oncogene.

This molecular driver induces unchecked granulocytic proliferation while preserving cell maturation, typically presenting with marked granulocytic leukocytosis, basophilia, or splenomegaly.

Clinically defined by fewer than 10% immature blast cells in the peripheral blood and bone marrow, patients in this phase are often asymptomatic or present with mild constitutional symptoms.

Personalize your experience

Follow Chronic phase chronic myeloid leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it